CIK 0001674416
- Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- Operating
- EIN
- 473173478
- Phone
- +1 617-315-4600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- 4 Open-market sale Chief Executive Officer sold 20,000 shares at $46.00 ($920,000)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale President sold 50,000 shares at $45.00 ($2,250,000)
- 4 Shares withheld for taxes Chief Executive Officer gave up 741 shares (to pay taxes)
- 4 Open-market sale Chief Executive Officer sold 20,000 shares at $42.03 ($840,600)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Ho Tony W acquired 10,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale President sold 85,220 shares at an average $40.40 ($3,443,037)
- 4 Shares withheld for taxes Chief Executive Officer gave up 748 shares (to pay taxes)
- 4 Open-market sale President sold 14,780 shares at $40.00 ($591,233)
Page 17 of 26 · 502 filings